docetaxel anhydrous and Carcinoma, Neuroendocrine
docetaxel anhydrous has been researched along with Carcinoma, Neuroendocrine in 10 studies
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Batman, E; Cairns, DA; Cave, J; Chau, I; Craig, Z; Faluyi, O; Howard, H; Hubner, R; Lamarca, A; Mansoor, W; McNamara, MG; Meyer, T; Reed, N; Sarker, D; Sharma, R; Swain, J; Valle, JW; Wadsley, J; Wall, L | 1 |
Damhuis, RA; den Bakker, MA; Derks, JL; Dingemans, AC; Groen, HJ; Smit, EF; Speel, EM; Thunnissen, E; van den Broek, EC; van Suylen, RJ | 1 |
Enoki, Y; Fujimoto, S; Fukui, A; Morishita, H; Okuyama, Y; Yoshida, N | 1 |
Cortes Vizcaino, V; Gil Salom, M; Moratalla Charcos, LM; Osca Garcia, JM; Pastor Navarro, T | 1 |
Chang, C; Cui, Y; Hu, S; Jin, J; Li, L; Li, X; Luo, J; Sun, Y; Yeh, S | 1 |
Attar, HE; Belkheiri, S; Benchakroun, N; Benider, A; Bennani, Z; Bouchbika, Z; Jouhadi, H; Safini, F; Sahraoui, S; Tawfiq, N | 1 |
Goloubeva, O; Hussain, A; Khan, MA; Lee, D; Tang, Y; Wang, L | 1 |
Ahmadzadeh, A; Babaei, M; Elahi, F; Hassanpour, K; Yadollahzadeh, M | 1 |
Fujiwara, Y; Kunitoh, H; Nokihara, H; Ohe, Y; Sekine, I; Tamura, T; Tsuta, K; Yamada, K; Yamamoto, N | 1 |
Earl, S; Gounaris, I; Lyons, B; Rahamim, J; Shivasankar, S; Yiannakis, D | 1 |
Trials
1 trial(s) available for docetaxel anhydrous and Carcinoma, Neuroendocrine
Article | Year |
---|---|
NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Clinical Trials, Phase II as Topic; Docetaxel; Fluorouracil; Humans; Irinotecan; Leucovorin; Multicenter Studies as Topic; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
Other Studies
9 other study(ies) available for docetaxel anhydrous and Carcinoma, Neuroendocrine
Article | Year |
---|---|
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Pemetrexed; Registries; Small Cell Lung Carcinoma; Taxoids; Vinblastine; Vinorelbine | 2017 |
A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Disseminated Intravascular Coagulation; Docetaxel; Fatal Outcome; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed; Treatment Failure | 2013 |
Large-cell neuroendocrine carcinoma of prostate. Case report.
Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Neuroendocrine; Combined Modality Therapy; Docetaxel; Fatal Outcome; Humans; Immunohistochemistry; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids | 2013 |
Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals.
Topics: Animals; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; HSP27 Heat-Shock Proteins; Humans; Male; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein Kinase Inhibitors; Receptor, Parathyroid Hormone, Type 1; Receptors, Androgen; Signal Transduction; Taxoids; Xenograft Model Antitumor Assays | 2016 |
[Primary large cell neuroendocrine carcinoma of the breast: a rare tumor in humans].
Topics: Antineoplastic Agents; Breast Neoplasms, Male; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Docetaxel; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Tamoxifen; Taxoids; Treatment Outcome | 2016 |
The relationship of neuroendocrine carcinomas to anti-tumor therapies in TRAMP mice.
Topics: Adenocarcinoma; Androgen Antagonists; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Neuroendocrine; Cell Proliferation; Docetaxel; Drug Therapy, Combination; Incidence; Male; Mice; Mice, Transgenic; Neoplasm Proteins; Prostatic Neoplasms; Survival Analysis; Taxoids | 2009 |
Neuroendocrine tumor of the gallbladder.
Topics: Antineoplastic Agents; Carcinoma, Neuroendocrine; Catheter Ablation; Cisplatin; Deoxycytidine; Docetaxel; Drug Therapy, Combination; Female; Gallbladder; Gallbladder Neoplasms; Gemcitabine; Humans; Indoles; Middle Aged; Pyrroles; Sunitinib; Taxoids; Ultrasonography | 2013 |
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Docetaxel; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids; Vinblastine; Vinorelbine | 2007 |
Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Dacarbazine; Docetaxel; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Quality of Life; Taxoids; Temozolomide | 2007 |